1. FDA’s work with the tri-agency task force for emergency diagnostics helped labs implement COVID-19 tests Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022 Subject(s): Advisory CommitteesCOVID-19 TestingGovernment AgenciesGovernment RegulationLaboratoriesUnited StatesUnited States. Food and Drug Administration
2. FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022 Subject(s): COVID-19 TestingDevice ApprovalGovernment RegulationUnited StatesUnited States. Food and Drug Administration
